# CLN8

## Overview
The CLN8 gene encodes the CLN8 transmembrane ER and ERGIC protein, which is integral to the endoplasmic reticulum (ER) and the ER-Golgi intermediate compartment (ERGIC). This protein is categorized as a transmembrane protein and plays a pivotal role in the transport of lysosomal enzymes, crucial for lysosome biogenesis and cellular homeostasis (di2018CLN8; Pesaola2021The). The CLN8 protein is involved in various cellular processes, including lipid metabolism, vesicular trafficking, and the regulation of endo-lysosomal dynamics, which are essential for maintaining neuronal function (Pesaola2021The). Mutations in the CLN8 gene are linked to neurodegenerative disorders such as Northern Epilepsy and variant late-infantile neuronal ceroid lipofuscinosis, highlighting its clinical significance (Ranta1999The; Kousi2011Update).

## Structure
The CLN8 protein is a transmembrane protein associated with the endoplasmic reticulum (ER) and the ER-Golgi intermediate compartment (ERGIC). It consists of 286 amino acids and has a molecular weight of approximately 33 kDa (Getty2010Interactions; Marotta2017NCLs). The protein contains five hydrophobic regions, including a TLC (TRAM-LAG1-CLN8) domain, which suggests potential roles in lipid synthesis and metabolism (Lonka2004Localization; Marotta2017NCLs). 

CLN8 is not glycosylated or proteolytically processed, indicating a lack of common post-translational modifications (Getty2010Interactions). The protein features a C-terminal dilysine signal (KKRP) that facilitates its retention in the ER through a COPI-mediated retrieval mechanism (Lonka2004Localization). Additionally, CLN8 interacts with various proteins involved in lipid synthesis, vesicular trafficking, autophagy, and apoptosis, highlighting its role in maintaining endo-lysosomal system dynamics (Pesaola2021The).

The specific molecular structure, including detailed primary, secondary, tertiary, and quaternary structures, as well as splice variant isoforms, has not been fully elucidated in the available literature (Lonka2004Localization; Pesaola2021The).

## Function
The CLN8 gene encodes a transmembrane protein primarily located in the endoplasmic reticulum (ER) and the ER-Golgi intermediate compartment (ERGIC). In healthy human cells, CLN8 functions as an ER cargo receptor, playing a crucial role in the transport of lysosomal enzymes from the ER to the Golgi complex, which is essential for lysosome biogenesis (di2018CLN8). The protein interacts with the COPI and COPII complexes, facilitating the proper trafficking of lysosomal enzymes, and contains specific signals for ER export and retrieval, ensuring its correct localization and function (di2018CLN8).

CLN8 is also involved in regulating endo-lysosomal dynamics and dendritic morphology. It maintains lysosomal pH and influences vesicular traffic, which is vital for cellular homeostasis and the degradation of macromolecules (Pesaola2021The). The protein's interaction with the PI3K/Akt pathway suggests a role in neuritic growth, and its deficiency can lead to dendritic atrophy and impaired lysosomal function (Pesaola2021The). CLN8's involvement in these processes highlights its importance in maintaining cellular and neuronal function, with deficiencies linked to neurodegenerative disorders such as neuronal ceroid lipofuscinoses (Pesaola2021The).

## Clinical Significance
Mutations in the CLN8 gene are associated with two main phenotypes: Northern Epilepsy (NE), also known as progressive epilepsy with mental retardation (EPMR), and variant late-infantile neuronal ceroid lipofuscinosis (vLINCL). NE is characterized by the onset of generalized tonic-clonic seizures between the ages of 5 and 10, followed by progressive mental retardation. This condition is primarily found in a remote population in northern Finland due to a founder effect and is associated with the p.Arg24Gly mutation in the CLN8 gene (Ranta1999The; BaduraStronka2021CLN8). 

In contrast, vLINCL presents with an earlier onset, typically between 2 and 7 years of age, and a more rapidly progressing disease course. Symptoms include ataxia, myoclonus, speech delay, developmental regression, visual failure, and seizures, leading to severe cognitive impairment and loss of mobility within a few years (BaduraStronka2021CLN8; Kousi2011Update). 

The CLN8 gene is also implicated in Gaucher disease as a potential genetic modifier, with certain alleles correlating with disease severity. CLN8's role in sphingolipid trafficking and its expression in immune cells, liver, and spleen suggest it may influence the phenotypic variation in Gaucher disease (Zhang2012Genome‐wide).

## Interactions
The CLN8 protein is involved in several interactions crucial for its function in lysosomal enzyme trafficking. It interacts with the COPII complex, specifically through the Sec24 subunits, which recognize an ER export signal within the CLN8 protein sequence. This interaction is essential for the ER-to-Golgi transport of lysosomal enzymes (di2018CLN8). CLN8 also interacts with the COPI complex, which facilitates its retrieval from the Golgi to the ER, mediated by a terminal KKXX signal (di2018CLN8).

The second luminal loop of CLN8 is critical for binding lysosomal enzymes, and mutations in this region can disrupt these interactions, affecting lysosome biogenesis (di2018CLN8). CLN8 forms part of the EGRESS complex with CLN6, which is responsible for transporting lysosomal enzymes to the ER-Golgi intermediate compartment (Pesaola2021The).

CLN8 also interacts with various proteins involved in cellular processes, including VAPA, syntaxin 8, and GATE16, which are associated with vesicular trafficking and lipid metabolism (Pesaola2021The). These interactions highlight CLN8's role in maintaining cellular homeostasis and its potential involvement in lipid synthesis and trafficking pathways (Getty2010Interactions).


## References


[1. (BaduraStronka2021CLN8) Magdalena Badura-Stronka, Anna Winczewska-Wiktor, Anna Pietrzak, Adam Sebastian Hirschfeld, Tomasz Zemojtel, Katarzyna Wołyńska, Katarzyna Bednarek-Rajewska, Monika Seget-Dubaniewicz, Agnieszka Matheisel, Anna Latos-Bielenska, and Barbara Steinborn. Cln8 mutations presenting with a phenotypic continuum of neuronal ceroid lipofuscinosis—literature review and case report. Genes, 12(7):956, June 2021. URL: http://dx.doi.org/10.3390/genes12070956, doi:10.3390/genes12070956. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes12070956)

[2. (Lonka2004Localization) Liina Lonka, Tarja Salonen, Eija Siintola, Outi Kopra, Anna‐Elina Lehesjoki, and Anu Jalanko. Localization of wild‐type and mutant neuronal ceroid lipofuscinosis cln8 proteins in non‐neuronal and neuronal cells. Journal of Neuroscience Research, 76(6):862–871, May 2004. URL: http://dx.doi.org/10.1002/jnr.20133, doi:10.1002/jnr.20133. This article has 39 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jnr.20133)

[3. (di2018CLN8) Alberto di Ronza, Lakshya Bajaj, Jaiprakash Sharma, Deepthi Sanagasetti, Parisa Lotfi, Carolyn Joy Adamski, John Collette, Michela Palmieri, Abdallah Amawi, Lauren Popp, Kevin Tommy Chang, Maria Chiara Meschini, Hon-Chiu Eastwood Leung, Laura Segatori, Alessandro Simonati, Richard Norman Sifers, Filippo Maria Santorelli, and Marco Sardiello. Cln8 is an endoplasmic reticulum cargo receptor that regulates lysosome biogenesis. Nature Cell Biology, 20(12):1370–1377, November 2018. URL: http://dx.doi.org/10.1038/s41556-018-0228-7, doi:10.1038/s41556-018-0228-7. This article has 84 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41556-018-0228-7)

[4. (Getty2010Interactions) Amanda L. Getty and David A. Pearce. Interactions of the proteins of neuronal ceroid lipofuscinosis: clues to function. Cellular and Molecular Life Sciences, 68(3):453–474, August 2010. URL: http://dx.doi.org/10.1007/s00018-010-0468-6, doi:10.1007/s00018-010-0468-6. This article has 46 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00018-010-0468-6)

[5. (Kousi2011Update) Maria Kousi, Anna-Elina Lehesjoki, and Sara E. Mole. Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses. Human Mutation, 33(1):42–63, November 2011. URL: http://dx.doi.org/10.1002/humu.21624, doi:10.1002/humu.21624. This article has 264 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.21624)

[6. (Zhang2012Genome‐wide) Clarence K. Zhang, Philip B. Stein, Jun Liu, Zuoheng Wang, Ruhua Yang, Judy H. Cho, Peter K. Gregersen, Johannes M.F.G. Aerts, Hongyu Zhao, Gregory M. Pastores, and Pramod K. Mistry. Genome‐wide association study of n370s homozygous gaucher disease reveals the candidacy of cln8 gene as a genetic modifier contributing to extreme phenotypic variation. American Journal of Hematology, 87(4):377–383, March 2012. URL: http://dx.doi.org/10.1002/ajh.23118, doi:10.1002/ajh.23118. This article has 47 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/ajh.23118)

[7. (Ranta1999The) Susanna Ranta, Yonghui Zhang, Barbara Ross, Liina Lonka, Elina Takkunen, Anne Messer, Julie Sharp, Ruth Wheeler, Kenro Kusumi, Sara Mole, Wencheng Liu, Marcelo Bento Soares, Maria de Fatima Bonaldo, Aune Hirvasniemi, Albert de la Chapelle, T. Conrad Gilliam, and Anna-Elina Lehesjoki. The neuronal ceroid lipofuscinoses in human epmr and mnd mutant mice are associated with mutations in cln8. Nature Genetics, 23(2):233–236, October 1999. URL: http://dx.doi.org/10.1038/13868, doi:10.1038/13868. This article has 232 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/13868)

[8. (Marotta2017NCLs) Davide Marotta, Elisa Tinelli, and Sara E. Mole. Ncls and er: a stressful relationship. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1863(6):1273–1281, June 2017. URL: http://dx.doi.org/10.1016/j.bbadis.2017.04.003, doi:10.1016/j.bbadis.2017.04.003. This article has 22 citations.](https://doi.org/10.1016/j.bbadis.2017.04.003)

[9. (Pesaola2021The) Favio Pesaola, Gonzalo Quassollo, Ana Clara Venier, Ana Lucía De Paul, Ines Noher, and Mariano Bisbal. The neuronal ceroid lipofuscinosis‐related protein cln8 regulates endo‐lysosomal dynamics and dendritic morphology. Biology of the Cell, 113(10):419–437, June 2021. URL: http://dx.doi.org/10.1111/boc.202000016, doi:10.1111/boc.202000016. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/boc.202000016)